DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Decoy Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.17+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $622.40K
- P/E (TTM)
- –
- Dividend yield
- –
Decoy Therapeutics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Market Cap | $766.57K | $164.85M |
| Enterprise Value | -$7.52M | $87.06M |
| PB Ratio | 0.18 | 2.03 |
| P/TBV Ratio | 0.18 | 2.31 |
Income (trailing twelve months)
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Operating Income | -$14.84M | -$21.44M |
| Net Income | -$14.45M | -$22.46M |
| EBITDA | -$14.82M | -$16.91M |
Returns
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -827.8% | -53.1% |
| Return on Assets (ROA) | -278.0% | -41.0% |
| Return on Capital Employed (ROCE) | -343.6% | -37.8% |
Balance sheet
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.29M | $62.42M |
| Net Cash (Debt) | $8.29M | $15.68M |
| Net Cash Per Share | $12.65 | $0.66 |
| Equity (Book Value) | $4.32M | $48.79M |
| Book Value Per Share | $6.59 | $1.36 |
| Tangible Book Value | $4.32M | $23.06M |
| Working Capital | $3.89M | $75.77M |
Financial position
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 1.83 | 3.30 |
| Quick Ratio | 1.77 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -$8.32M | -$12.35M |
Efficiency
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$1.31M | -$703.34K |
| Employee Count | 11 | 74 |
Dividends and yields
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -1885.0% | -22.7% |
Shares
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 655,185 | 58,179,650 |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 580,375 | 49,173,100 |
| Shares Held by Insiders | 11.4% | 11.6% |
| Shares Held by Institutions | 0.66% | 59.4% |
Scores
| Measure | Decoy Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | -20.23 | -0.24 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Decoy Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.